Transjugular Intrahepatic Portosystemic Stent-Shunt (TIPSS) in the management of portal hypertension
These guidelines are new and have been produced in collaboration with the BSIR and BASL.
Diagnosis and therapy of genetic haemochromatosis (review and 2017 update)
doi: 10.1111/bjh.15164
BSG Winter Pathology Meeting
A 2-day meeting aimed at Senior Trainees & Consultants in Histopathology.
BSG and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis
These guidelines on the management of primary sclerosing cholangitis (PSC) were commissioned by the BSG liver section.
Ex-situ machine perfusion for extracorporeal preservation of livers for transplantation
Interventional procedures guidance Published: 16 January 2019
Alcohol care teams: reducing acute hospital admissions and improving quality of care
Alcohol-Related Disease: Meeting the challenge of improved quality of care and better use of resources
Recently, much attention has focused on social policy and measures to reduce drinking.
Advanced Hepatology Training posts – 2019 entry
These ATPs are approved for advanced training in Hepatology, including experience in a transplant unit, with a view to subspecialty accreditation providing other requirements are met.
BSG Decompensated Cirrhosis Care Bundle
A video on the BSG Decompensated Cirrhosis Care Bundle
BSG 2018 prize winners
The following prizes were awarded at BSG 2018 in Liverpool
£7.3m award aims to create new breakthrough therapies
A recently formed health consortium has been awarded £7 million by Innovate UK to ensure more patients benefit from a new generation of breakthrough therapies.
Alcohol identification and intervention in English emergency departments
Alcohol screening together with referral or intervention is becoming part of routine practice in England.
Caution about the use of ulipristal acetate (Esmya)
Esmya is indicated for the pre-operative and intermittent treatment of moderate to severe symptoms of uterine fibroids in women of reproductive age. However, following reports of serious liver injury, the European Medicines Agency (EMA), and the Medicines and Healthcare products Regulatory Agency (MHRA) have issued the following advice.
BSG and UKPBC primary biliary cholangitis treatment and management guidelines
Hirschfield GM, et al. Gut 2018;0:1–27. doi:10.1136/gutjnl-2017-315259